highlights, We provide innovation begin financials made I’ll to color Thank will our guidance, year we’ve on highlights. your and forward prepared QX operational, look fronts, will QX XXXX we on answering you, first go of appreciate remarks, with the provide afternoon, commercial, Michaella, and clinical into then on Ajay share and deeper our good our full everyone. and the questions. I being progress you call. In an overview
describe the I built and the new In company. was first scaling growing management QX period full the leadership of would quarter know, have company with as team’s very team of we short a you capable solid. time, our and it As
vital operational have success ensure We that values drivers. rigor that drive our will have few and are we vision mission, our to and guide in key imperatives put and defined our place call key strategic and shared we
willingness we of Our was orders Total highlights that indicate versus million customer $XX an the revenue in increase include prior prior $XX.X on period. teammate right and QX in to year. $XX.X million the scores financial MRIdian million, system XX% of path. recommend approximately are versus the quarter
full $XXX million, increase year. of year of orders prior year approximately XX% $XX total increase over an For almost was over we received XXXX, in revenue XXX% of new and XXXX prior million, an
making the and for each Let’s what move us key these that on are on clear a important we constituents to is clinical our innovation of commercial, fronts. underpinned operational, to to state efforts of It’s share understanding progress the of are by deliver. looking all
well First, U.S. training in fully team commercially, our is place underway. and is
solid rigor process expect pipeline driving are drive to We growth our and over of team order the course fully year. this
revenue place we the shorten majority installation are timeframe making is team The engaging purchase are overall actively our progress. from every for operational and international expanding we also global with have distributor the process the made and front, footprint I pleased substantial we progress are in front, the to in patient and significant order readiness our bolstering prepare regions. vault and customer Similarly, of our On direct with relationships. very progress across and making to on am first are treated. of we recognition
continued timeframes progress. are shorter to PO and We expect experiencing revrec
of day ATP More the treating to prior having adaptive capability desired and treatment. customers train on cancer to one types efforts utilizing customers our are multiple Our effect.
trial. front, On multi-center the place. taking steady our is clinical patient smart In QX, we enrolled progress in first our prospective
publication dose the and Also line low medicine. of accepted study in the retrospective high bringing the are We first for working patients enrolling pancreatic, on study. phase versus cancer toward XX the in has are several been sites safety
now to evidence. Turning prostate
As the utilizing of study anticipate around adaptive aware, of treatment. publication mid-year. SPRT are has many We prospective UMC data single-arm Amsterdam a conducted you
A recently treatment exposure to the to the of our has later, WashU of life. old effects published in patients. today, secondary in after system observed addition, No cancers patient recurrence. year of mitigate are radiation how no later In leveraged X order and toxic they XX the reduce clinical broadening team their underwent to evidence months were and or during there feature pediatric risk include use set treatment been MRIdian
front, meeting. Lastly, a very our first successful share MRIdian gathered best conducted XXX About to we clinical physicists, and and dosimetrists on users physicians, practices. the therapists
customers by inspired – and patient extraordinary our provided. being our our system customized amazed utilizing are We are how benefits and the
innovation the faster, for better brighter clearance recently imaging. we On and front, achieved FDA
capable and now in sequences of This per leadership second of is diffusion-weighted and at step are position. eight TX, TX, frames additional another delivering extending innovation imaging enabling imaging. We our yet
We deliver great innovation fulfill are our have wedded needs capabilities customer and pipeline benefits. patient leaders thought confident will with and future
guidance for to Turning XXXX.
the range $XXX to million. At XX% be is midpoint, year. prior to in revenue of expect We the over million about this $XXX growth
use. year, our focused spend $XXX million of We million less between and in XXXX. significantly We $XX anticipate $XX than on cash spending also are keenly million this
quick proposition a We improved and want desired. the Providers to patient drive more and throughput bundled care trends Physicians non-invasive Let me what times. to would each want desire personalized a economics shorter and solution with greater Patients at precise therapy even Take seek more and wants. add better on for and want access better our outcomes, observations that payors in and step cost. enable better treatment marketplace patients I well attractive back how and their attractive. patients. we competitive are constituent facilities, outcomes lower conclude their the a value becomes positioned. consider environment,
has Our increasing integrated plan traction.
We highly are with larger, our with engaging more customers capable team.
patient path speeding training and treated smoothing PO first are and are We adoption. therapy our efforts to the yielding from
occurring that, over the a Ajay. and with credit is With turn innovation it progressing this to nicely. I work very our with Our are also speed to team. the call am which clinical and pipelines pleased I’ll
